Basic Information
Bexorg is the developer of whole-brain perfusion technology, aimed at supporting brain research and therapeutic advancements. The company provides a proprietary technology capable of maintaining and monitoring an intact human brain, enabling researchers and drug developers to conduct detailed studies on neurological diseases. The company is currently focused on neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and frontotemporal dementia.
Bexorg Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2021
--

